Rab3a promotes brain tumor initiation and progression. 2014

Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.

The Rab protein family is composed of small GTP-binding proteins involved in intracellular vesicle trafficking. In particular, Rab3a which is one of four Rab3 proteins (a, b, c, and d isoforms) is associated with synaptic vesicle trafficking in normal brain. However, despite the elevated level of Rab3a in tumors, its role remains unclear. Here we report a tumorigenic role of Rab3a in brain tumors. Elevated level of Rab3a expression in human was confirmed in both glioma cell lines and glioblastoma multiforme patient specimens. Ectopic Rab3a expression in glioma cell lines and primary astrocytes promoted cell proliferation by increasing cyclin D1 expression, induced resistance to anti-cancer drug and irradiation, and accelerated foci formation in soft agar and tumor formation in nude mice. The overexpression of Rab3a augmented the tumorsphere-forming ability of glioma cells and p53(-/-) astrocytes and increased expression levels of various stem cell markers. Taken together, our results indicate that Rab3a is a novel oncogene involved in glioma initiation and progression.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
April 2008, BMC medicine,
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
July 2018, Breast cancer research : BCR,
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
December 2025, Cellular oncology (Dordrecht, Netherlands),
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
May 2022, Inflammatory bowel diseases,
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
January 2021, Cellular and molecular gastroenterology and hepatology,
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
February 2017, Cancer cell,
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
November 2015, Cancer prevention research (Philadelphia, Pa.),
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
February 2001, Current opinion in genetics & development,
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
June 2022, Trends in cancer,
Jun-Kyum Kim, and Seung-Yup Lee, and Chang-Won Park, and Suk-Hwang Park, and Jinlong Yin, and Jaebong Kim, and Jae-Bong Park, and Jae-Yong Lee, and Hyunggee Kim, and Sung-Chan Kim
December 2018, Blood,
Copied contents to your clipboard!